Treatment of Helicobacter pylori infection in patients with duodenal ulcer: A cost-benefit study;Tratamiento de la infección por Helicobacter pylori en pacientes con ulcéra duodenal: Estudio de costo-beneficio

Revista Medica de Chile

Volumn 128, Issue 4, 2000, Pages 367-377

  Rollán R, Antonio ^a,c   Giancaspero P, Rossana ^a,b   Acevedo G, Claudia ^a,b   Fuster S, Francisco ^a   Hola Ch, Karen ^a  

^a HOSPITAL NAVAL ALMIRANTE NEF   (Chile)

^b Enfermera Universitaria ^*

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Amoxycillin; Antibiotics; Clarithromycin; Combined; Cost benefit analysis; Helicobacter pylori; Proton pump

Indexed keywords

ANTIINFECTIVE AGENT; ANTIULCER AGENT; PROTON PUMP;

ADULT; ARTICLE; COST BENEFIT ANALYSIS; DRUG COMBINATION; DRUG EFFECT; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; PROTON PUMPS; TREATMENT OUTCOME;

EID: 0034170824     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. CHIBA N, MATISKO A, SINCLAIR P, THOMSON AB. Helicobacter pylori: from bench to bedside. Can J Gastroenterol 1997; 11: 589-96.
2. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272: 65-9.
3. WOTHERSPOON AC. Helicobacter pylori infection and gastric lymphoma. Br Med Bull 1998; 54: 79-85.
4. LEE J, O'MORAIN C. Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines. Gastroenterology 1997; 113: S99-106.
5. SCHEIMAN JM, CUTLER AF. Helicobacter pylori and gastric cancer [In Process Citation]. Am J Med 1999; 106: 222-6.
6. ROLLAN A. Eradication of Helicobacter pylori in developing countries. Rev Med Chile 1997; 125: 939-49.
7. AXON AT. Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives. Gut 1998; 43 Suppl 1: S70-3.
8. HUANG JQ, HUNT RH. Review: eradication of Helicobacter pylori. Problems and recommendations. J Gastroenterol Hepatol 1997; 12: 590-8.
9. HARRIS A. Current regimens for treatment of Helicobacter pylori infection. Br Med Bull 1998; 54: 195-205.
10. FORNE M, VIVER JM, ESTEVE M, FERNÁNDEZ-BANARES F, LITE J, ESPINOS JC, QUINTANA S, SALAS A, GARAU J. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. Am J Gastroenterol 1998; 93: 35-8.
11. GODDARD AF, SPILLER RC. Helicobacter pylori eradication in clinical practice: one-week low-dose triple therapy is preferable to classical bismuth based triple therapy. Aliment Pharmacol Ther 1996; 10: 1009-13.
12. HAWKEY CJ, TULASSAY Z, SZCZEPANSKI L, VAN RENSBURG CJ, FILIPOWICZ-SOSNOWSKA A, LANAS A, WASON CM, PEACOCK RA, GILLON KR. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention, [published erratum appears in Lancet 1998 Nov 14;352(9140): 1634]. Lancet 1998; 352: 1016-21.
13. CAMMAROTA G, CIANCI R, GASBARRINI G: Eradication of Helicobacter pylori in routine clinical practice: doubts and uncertainties. Hepatogastroenterology 1999; 46: 312-5.
14. LEE JM, BRESLIN NP, HYDE DK, BUCKLEY MJ, O'MORAIN CA. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999; 13: 489-96.
15. BANATVALA N, DAVIES GR, ABDI Y, CLEMENTS L, RAMPTON DS, HARDIE JM, FELDMAN RA. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994; 35: 1562-6.
16. GRAFFAR M. Une méthode de classification sociale d'echantillons de population. Courier 1956; 6: 445-9.
17. ROLLAN A, GIANCASPERO R, ARRESE M, FIGUEROA C, VOLLRATH V, SCHULTZ M, DUARTE I, VIAL P. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection after antibiotic treatment. Am J Gastroenterol 1997; 92: 1268-74.
18. DESROCHES JJ, LAHAIE RG, PICARD M, MORAIS J, DUMONT A, GAUDREAU C, PICARD D, CHARTRAND R. Methodological validation and clinical usefulness of carbon-14-urea breath test for documentation of presence and eradication of Helicobacter pylori infection. J Nucl Med 1997; 38:1141-5.
19. PAUKER S, KASSIRER J. Decision Analysis. In: Bailar J, Mosteller F, eds. Medical Uses of Statistics. Boston: Massachusetts Medical Society, 1992: 159-79.
20. KASSIRER J, MOSKOWITZ A, LAU J, PAUKER S. Decision analysis: a progress report. Ann Intern Med 1987; 106: 275-91.
21. BATTAGLIA G, DI MARIO F, VIGNERI S, VIANELLO F, BENVENUTI ME, DONISI PM, STRACCA-PANSA V, PASQUINO M. Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series. Ital J Gastroenterol Hepatol 1998; 30: 370-4.
22. DELTENRE M, GEBOES K, ECTORS N, BURETE A, DEBONGNIE JC, LAMY V, CADRANEL S, COLEMONT L, DE KOSTER E, DE PREZ C, DEPREZ P, DUMONCEAU JL, GLUPCZUNSKI Y, MELANGE M, PEETERS M, RAMDANI B, SCAILLON M. The 1998 national Belgian consensus meeting on HP-related diseases: an extensive summary. The HP Belgian contact group organized in CHU Brugmann, Brussels. Acta Gastroenterol Belg 1998; 61: 299-302.
23. BORODY TJ, SHORTIS NP, REYES E. Eradication therapies for Helicobacter pylori. J Gastroenterol 1998; 33(Suppl 10): 53-6.
24. COELHO LG, PASSOS MC, CHAUSSON Y, COSTA EL, MAIA AF, BRANDAO MJ, RODRIGUES DC, CASTRO LP. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenterol 1992; 27: 362-6.
25. SEGURA AM, GUTIÉRREZ O, OTERO W, ÁNGEL A, GENTA RM, GRAHAM DY. Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11: 529-32.
26. MITCHELL HM, HU P, CHI Y, CHEN MH, LI YY, HAZELL SL. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998; 114: 256-61.
27. RAMÍREZ-RAMOS A, GILMAN RH, LEÓN-BARUA R, RECAVARREN-ARCE S, WATANABE J, SALAZAR G, CHECKLEY W, MCDONALD J, VALDEZ Y, CORDERO L, CARRAZCO J. Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University. Clin Infect Dis 1997; 25: 1027-31.
28. SCHMID CH, WHITING G, CORY D, ROSS SD, CHALMERS TC. Omeprazole Plus Antibiotics in the Eradication of Helicobacter pylori Infection: A Meta-Regression Analysis of Randomized, Controlled Trials. Am J Ther 1999; 6: 25-36.
29. BAZZOLI F, ZAGARI RM, FOSSI S, POZZATO P, ALAMPI G, SIMONI P, SOTTILI S, RODA A, RODA E. Short-term low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol & Hepatol 1994; 6:773-7.
30. CALVET X, LÓPEZ-LORENTE M, CUBELLS M, BARE M, GÁLVEZ E, MOLINA E. Two-week dual vs one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial. Aliment Pharmacol Ther 1999; 13: 781-6.
31. CHEN S, CHEN Z, BEI L. Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection. Chung Hua Nei Ko Tsa Chib 1996; 35: 799-802.
32. LAINE L, ESTRADA R, TRUJILLO M, FUKANAGA K, NEIL G. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996; 10:1029-33.
33. LAINE L, SUCHOWER L, FRANTZ J, CONNORS A, NEIL G. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. Am J Gastroente-rol 1998; 93: 2106-12.
34. LIM AG, WALKER C, CHAMBERS S, GOULD SR. Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin. Aliment Pharmacol Ther 1997; 11: 537-40.
35. HENRY A, BATEY RG. Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the Help Study. Am J Gastroenterol 1999; 94: 811-5.
36. MOSHKOWITZ M, BRILL S, KONIKOFF FM, REIF S, ARBER N, HALPERN Z. The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia. J Am Geriatr Soc 1999; 47: 720-2.